A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 [lapatinib] in Combination With Trastuzumab [Herceptin]

Trial Profile

A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 [lapatinib] in Combination With Trastuzumab [Herceptin]

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2012

At a glance

  • Drugs Lapatinib; Trastuzumab
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Aug 2012 Actual end date (1 Feb 2005) added as reported by ClinicalTrials.gov.
    • 21 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top